DE69017687D1 - Felincalicivirus-capsid-protein und nukleotidsequenz. - Google Patents

Felincalicivirus-capsid-protein und nukleotidsequenz.

Info

Publication number
DE69017687D1
DE69017687D1 DE69017687T DE69017687T DE69017687D1 DE 69017687 D1 DE69017687 D1 DE 69017687D1 DE 69017687 T DE69017687 T DE 69017687T DE 69017687 T DE69017687 T DE 69017687T DE 69017687 D1 DE69017687 D1 DE 69017687D1
Authority
DE
Germany
Prior art keywords
capsid protein
felincalicivirus
nucleotide sequence
recombinant dna
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69017687T
Other languages
English (en)
Other versions
DE69017687T2 (de
Inventor
Richard Wardley
Leonard Post
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE69017687D1 publication Critical patent/DE69017687D1/de
Application granted granted Critical
Publication of DE69017687T2 publication Critical patent/DE69017687T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69017687T 1989-07-21 1990-07-09 Felincalicivirus-capsid-protein und nukleotidsequenz. Expired - Fee Related DE69017687T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38390989A 1989-07-21 1989-07-21
US40898989A 1989-09-18 1989-09-18
PCT/US1990/003753 WO1991001332A1 (en) 1989-07-21 1990-07-09 Feline calicivirus capsid protein and nucleotide sequence

Publications (2)

Publication Number Publication Date
DE69017687D1 true DE69017687D1 (de) 1995-04-13
DE69017687T2 DE69017687T2 (de) 1995-10-19

Family

ID=27010385

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69017687T Expired - Fee Related DE69017687T2 (de) 1989-07-21 1990-07-09 Felincalicivirus-capsid-protein und nukleotidsequenz.

Country Status (9)

Country Link
EP (1) EP0484382B1 (de)
JP (1) JPH04506900A (de)
AT (1) ATE119545T1 (de)
AU (1) AU629381B2 (de)
CA (1) CA2055598C (de)
DE (1) DE69017687T2 (de)
DK (1) DK0484382T3 (de)
ES (1) ES2069742T3 (de)
WO (1) WO1991001332A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989561A (en) * 1991-03-07 1999-11-23 Virogenetics Corporation Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
ATE193725T1 (de) * 1992-02-28 2000-06-15 Chemo Sero Therapeut Res Inst Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes gen
ES2080023B1 (es) * 1994-07-08 1996-08-16 Iberica Cyanamid Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes.
FR2741806B1 (fr) * 1995-11-30 1998-02-20 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
FR2751223B1 (fr) 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
US6231863B1 (en) 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
WO2000076538A1 (en) * 1999-06-10 2000-12-21 Michigan State University Feline calicivirus isolated from cat urine and vaccines thereof
FR2796396A1 (fr) * 1999-07-16 2001-01-19 Merial Sas Gene de calicivirus felin et vaccin recombine les incorporant
US6541458B1 (en) 1999-07-16 2003-04-01 Merial Feline calicivirus genes and vaccines in particular recombinant vaccines
FR2796282B1 (fr) * 1999-07-16 2001-10-26 Merial Sas Vaccin inactive contre la calicivirose feline
FR2796397B1 (fr) * 1999-07-16 2006-09-01 Merial Sas Genes de calicivirus felin et vaccins notamment vaccins recombines
WO2005080416A1 (en) * 2004-01-20 2005-09-01 Pharmacia & Upjohn Company Llc Feline calicivirus vaccines
WO2007012944A2 (en) * 2005-07-28 2007-02-01 Pfizer Products Inc. Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
CN108473539B (zh) * 2015-12-23 2022-03-22 英特维特国际股份有限公司 猫杯状病毒疫苗
CN109207441B (zh) * 2018-08-12 2022-05-27 扬州大学 重组杆状病毒表达猪圆环病毒3型Cap蛋白及其构建方法与引物

Also Published As

Publication number Publication date
CA2055598C (en) 1998-12-08
DK0484382T3 (da) 1995-07-24
CA2055598A1 (en) 1991-01-22
AU629381B2 (en) 1992-10-01
EP0484382A1 (de) 1992-05-13
EP0484382B1 (de) 1995-03-08
WO1991001332A1 (en) 1991-02-07
ES2069742T3 (es) 1995-05-16
JPH04506900A (ja) 1992-12-03
AU6037990A (en) 1991-02-22
DE69017687T2 (de) 1995-10-19
ATE119545T1 (de) 1995-03-15

Similar Documents

Publication Publication Date Title
DE69017687D1 (de) Felincalicivirus-capsid-protein und nukleotidsequenz.
DE69033425T2 (de) HCV-Isolat J-1
DE58906121D1 (de) Rekombinantes Vaccinia-Virus MVA.
CH0229046H1 (de) Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech
ATE334216T1 (de) Impstoff gegen felines immunodefizienz-virus
CY1105597T1 (el) Ανοσοθεραπευτικες μεθοδοι χρησιμοποιωντας επιτοπους των wt-1 και gata-1
DE69131580T2 (de) GDF-1 und UOG1 Proteine
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
DK0963377T3 (da) Interleukin-19
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
DE69230671T2 (de) Impfstoffe gegen actinobacillus pleuropneumonie
DK0434605T3 (da) Ny fremgangsmåde til fremstilling af ikke-fusioneret protein i E.coli
FI20070041A (fi) Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
NO922421L (no) Collagenbindende protein, samt fremstilling derav
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
DK0805204T3 (da) Bitestikel - specifikt receptorprotein og anvendelse heraf
IL78278A0 (en) Process for the production of polypeptides,dna sequence encoding desired polypeptide human somatomedin c polypeptide and recombinant dna molecules
DK130290D0 (da) Lymfokiner, dna-sekvenser, som koder for disse lymfokiner og farmaceutiske midler indeholdende disse lymfokiner
DK1176192T3 (da) Helicobacter felis-vaccine
NO178704C (no) DNA-sekvens som koder for protein med IRF-1-aktivitet, ekspresjonsvektor inneholdende denne, anvendelse av IRF-1 for å öke ekspresjon, vertscelle transformert med ekspresjonsvektoren, og protein med IRF-1-aktivitet
AR025198A1 (es) Compuestos para el tratamiento de trastornos infecciosos y del sistema inmune y metodos para su uso

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PHARMACIA & UPJOHN CO., KALAMAZOO, MICH., US

8339 Ceased/non-payment of the annual fee